增加的CXCL1表达有助于儿童克罗恩病的发展,并作为诊断标记:基于综合生物信息学的重新分析
1Department of Gastroenterology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56, Nanlishi Road, Xicheng District, Beijing 100045, China.
Cytokine
|June 3, 2025
概括
儿科克罗恩病 (PCD) 中CXCL1升高,可能作为诊断标记物. 这一发现可能会导致对患有PCD的儿童改善治疗策略.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 儿科克罗恩病 (PCD) 是一种严重的疾病,缺乏有效的诊断标记.
- 了解分子机制对于开发更好的诊断和治疗方法至关重要.
研究的目的:
- 为了确定PCD的新型诊断标志物.
- 探索PCD背后的分子机制.
- 调查PCD的潜在治疗点.
主要方法:
- 从基因表达综合 (GEO) 数据库下载和分析PCD数据集.
- 使用生物信息学分析 (Limma,GO,KEGG,GSEA,PPI) 识别了差异表达基因 (DEG) 和枢纽基因.
- 使用qRT-PCR验证了患者样本中的CXCL1表达,并通过ROC分析评估了其诊断价值.
主要成果:
- 确定了71个DEG和15个枢纽基因,其中CXCL1在PCD肠道组织中显著上调.
- CXCL1表达与免疫透相关,并且在IL-17和NF-kappa B信号通路中得到丰富.
- 在区分PCD患者中,CXCL1表现出高的诊断准确性 (AUC>0.90).
结论:
- CXCL1涉及PCD病原体,并显示出作为一种有价值的诊断生物标志物的潜力.
- 准CXCL1可能为儿科克罗恩病提供新的治疗途径.
- 对CXCL1作用的进一步研究可以提高PCD管理和治疗结果.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...


